WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke ALLUCENT CONSULTING wurde als Wortmarke am 15.09.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1712003 |
| Länder | 
|
| Basismarke |
Nr. 97318068,
17. März 2022
|
| Anmeldedatum | 15. September 2022 |
| Ablaufdatum | 15. September 2032 |
Markeninhaber
271 Waverly Oaks Rd. Suite 208
Waltham MA 02452
US
Waltham MA 02452
US
Markenvertreter
101 California Street
San Francisco CA 94111
US
Waren und Dienstleistungen
09
Downloadable computer application software for use in
connection with the collection, tracking, retrieval,
validation, summarization, statistical analysis and
presentation of data used in the areas of medical research
and product regulatory approval, environmental health,
health care, and in relation to the design, research,
development, and testing of new medical products and
devices; downloadable computer application software for
providing telehealth, telemedicine, remote care and virtual
health care services to patients; downloadable computer
application software for use in connection with collection,
tracking, retrieval, validation, summarization, statistical
analysis and presentation of remotely gathered
patient-generated health data for use in clinical studies
35
Data management, namely, abstraction and collection of
medical data from clinical tests for business purposes;
market research and business marketing consulting services
in the pharmaceutical, biotechnology, medical device, and
diagnostics industries
42
Programming of software for managing and collecting
patient-generated health data for scientific research
purposes; cloud computing featuring software that allows
users to collect, review, analyze and report on clinical
research; technical support services, namely, installation
and remote administration of software, and troubleshooting
of software problems and hosted software applications, all
for use in connection with medical research and product
regulatory approval, environmental health, health care, and
in relation to the design, research, development, and
testing of new medical products and devices; cloud computing
featuring software for providing telehealth, telemedicine,
remote care and virtual health care services to patients;
cloud computing featuring software that allows users to
collect, track, retrieve, validate, summarize, statistically
analyze and present data used in the areas of medical
research and product regulatory approval, environmental
health, health care, and in relation to the design,
research, development, and testing of new medical products
and devices; cloud computing featuring software to
aggregate, integrate, transfer and manage data generated
from home health and remote monitoring devices and
applications and health-related smart-phone applications;
cloud computing featuring software that provides integrated
workflows, analytics, visualizations, and reporting features
to deliver, process, analyze, elevate, and display
patient-generated health data; cloud computing featuring
software that integrates remotely collected health data into
databases, systems, platforms, applications, and software
that inform clinical research, remote monitoring, and care
management; hosting of web-based portal for study sponsors
and contract research organizations (CROS) to build
programs, enroll members, automate actions, and
visualize/analyze data in connection with clinical studies;
technical consulting services, namely, evaluating the safety
of pharmaceutical, medical, cosmetic and consumer devices
and products in clinical development or in commercial
production; consulting services for others in the field of
design, planning, and implementation project management of
clinical trials; analysis of statistical data relating to
clinical trials for pharmaceuticals, biotechnology, medical
devices and diagnostics for scientific research
45
Development of regulatory compliance strategies in the field
of medical research, namely, regulatory compliance in drug,
biologic, cosmetic and medical device development
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 28. Juni 2023 | 2023/26 Gaz | EM | Ablehnung |
| 01. Mai 2023 | 2023/18 Gaz | GB | Ablehnung |
| 21. April 2023 | 2023/17 Gaz | RU | Ablehnung |
| 15. September 2022 | 2023/4 Gaz | US | Eintragung |
ID: 141712003